Specifically, CDAI reduced the prevalence of NAFLD by lowering the levels of these inflammatory factors, with WBC, neutrophils, lymphocytes, and C-reactive protein accounted for 20.9, 12.8, 11.5, and 10.2% of the association, respectively (all p for mediation <0.05). The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.